Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease

Name: Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
Published: 2023
License: Public Domain

Icahn School of Medicine at Mount Sinai · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

crohn-s-disease

crohn's disease, entocort ec induction, double blind, controlled safety/tolerability trial, open label exploratory efficacy trial, mild-to-moderate crohn's disease, chinese herbal therapy, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease

Related documents